Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Diadema Partners

Latest statistics and disclosures from Diadema Partners's latest quarterly 13F-HR filing:

Central Index Key (CIK): 0002026172

Tip: Access up to 7 years of quarterly data

Positions held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for Diadema Partners

Diadema Partners holds 106 positions in its portfolio as reported in the September 2025 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Share Count	Share Price
Jazz Pharmaceuticals Shs Usd (JAZZ)	5.8	$23M	173k	131.80	View chart
Soleno Therapeutics (SLNO)	5.7	$22M	327k	67.60	View chart
Uniqure Nv SHS Put Option (QURE)	4.5	$18M	300k	58.37	View chart
Regeneron Pharmaceuticals (REGN)	4.3	$17M	30k	562.27	View chart
Viking Therapeutics (VKTX)	4.0	$16M	599k	26.28	View chart
Bristol Myers Squibb (BMY)	3.6	$14M	310k	45.10	View chart
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)	3.4	$13M	20k	666.18	View chart
BioMarin Pharmaceutical (BMRN)	2.9	$12M	213k	54.16	View chart
Avidity Biosciences Ord (RNA)	2.6	$10M	230k	43.57	View chart
Agios Pharmaceuticals Call Option (AGIO)	2.3	$8.9M	222k	40.14	View chart
Ultragenyx Pharmaceutical (RARE)	2.2	$8.5M	283k	30.08	View chart
Incyte Corporation Call Option (INCY)	2.2	$8.5M	100k	84.81	View chart
Intellia Therapeutics Call Option (NTLA)	2.1	$8.1M	470k	17.27	View chart
Vaxcyte (PCVX)	2.0	$7.9M	218k	36.02	View chart
Eli Lilly & Co. Put Option (LLY)	2.0	$7.6M	10k	763.00	View chart
Apogee Therapeutics (APGE)	1.9	$7.6M	192k	39.73	View chart
Crispr Therapeutics Namen Akt Call Option (CRSP)	1.9	$7.3M	112k	64.81	View chart
Novo-nordisk A S Adr (NVO)	1.8	$6.9M	125k	55.49	View chart
Harmony Biosciences Hldgs In (HRMY)	1.8	$6.9M	250k	27.56	View chart
Bridgebio Pharma Call Option (BBIO)	1.7	$6.8M	131k	51.94	View chart
Mannkind Corp Com New (MNKD)	1.7	$6.7M	1.3M	5.37	View chart
Ionis Pharmaceuticals Call Option (IONS)	1.7	$6.5M	100k	65.42	View chart
Roivant Sciences SHS (ROIV)	1.6	$6.4M	420k	15.13	View chart
Indivior Ord (INDV)	1.6	$6.1M	254k	24.11	View chart
Moderna (MRNA)	1.5	$5.7M	222k	25.83	View chart
Ascendis Pharma A/s Sponsored Adr (ASND)	1.4	$5.5M	28k	198.81	View chart
Praxis Precision Medicines I Com New Put Option (PRAX)	1.4	$5.3M	100k	53.00	View chart
Neurocrine Biosciences (NBIX)	1.4	$5.3M	38k	140.38	View chart
Alnylam Pharmaceuticals (ALNY)	1.2	$4.6M	10k	456.00	View chart
Immunocore Hldgs Ads (IMCR)	1.2	$4.5M	124k	36.33	View chart
Cogent Biosciences (COGT)	1.1	$4.3M	298k	14.36	View chart
Nektar Therapeutics Com New (NKTR)	1.1	$4.3M	75k	56.90	View chart
Terns Pharmaceuticals (TERN)	1.1	$4.1M	548k	7.51	View chart
Upstream Bio Call Option (UPB)	1.0	$3.8M	200k	18.81	View chart
Scholar Rock Hldg Corp Call Option (SRRK)	1.0	$3.7M	100k	37.24	View chart
Arcturus Therapeutics Hldg I (ARCT)	0.9	$3.7M	200k	18.43	View chart
Abivax Sa Sponsored Ads (ABVX)	0.9	$3.5M	42k	84.41	View chart
Recursion Pharmaceuticals In Cl A Call Option (RXRX)	0.9	$3.4M	698k	4.88	View chart
Protagonist Therapeutics (PTGX)	0.9	$3.4M	51k	66.43	View chart
Zymeworks Del Call Option (ZYME)	0.9	$3.4M	197k	17.08	View chart
Mereo Biopharma Group Spon Ads Put Option (MREO)	0.8	$3.2M	1.6M	2.06	View chart
Biosante Pharmaceuticals (ANIP)	0.7	$2.9M	31k	91.60	View chart
Revolution Medicines (RVMD)	0.7	$2.8M	59k	46.70	View chart
Scpharmaceuticals Call Option (SCPH)	0.7	$2.6M	462k	5.67	View chart
Replimune Group Call Option (REPL)	0.7	$2.6M	612k	4.19	View chart
Arbutus Biopharma Call Option (ABUS)	0.6	$2.3M	516k	4.54	View chart
Ardelyx (ARDX)	0.6	$2.2M	400k	5.51	View chart
Corcept Therapeutics Incorporated Put Option (CORT)	0.6	$2.2M	27k	83.11	View chart
Tg Therapeutics (TGTX)	0.6	$2.2M	61k	36.12	View chart
Gossamer Bio Call Option (GOSS)	0.6	$2.2M	825k	2.63	View chart
Capricor Therapeutics Com New Call Option (CAPR)	0.6	$2.2M	300k	7.21	View chart
Alkermes SHS (ALKS)	0.6	$2.2M	72k	30.00	View chart
ACADIA Pharmaceuticals Call Option (ACAD)	0.5	$1.9M	89k	21.34	View chart
Urogen Pharma (URGN)	0.5	$1.8M	90k	19.95	View chart
Mbx Biosciences Call Option (MBX)	0.4	$1.8M	100k	17.50	View chart
Altimmune Com New Call Option (ALT)	0.4	$1.7M	463k	3.77	View chart
Ocular Therapeutix Call Option (OCUL)	0.4	$1.6M	137k	11.69	View chart
Vistagen Therapeutics Ord (VTGN)	0.4	$1.6M	450k	3.55	View chart
Tectonic Therapeutic Call Option (TECX)	0.4	$1.6M	100k	15.69	View chart
Summit Therapeutics Call Option (SMMT)	0.4	$1.5M	75k	20.66	View chart
Pacira Pharmaceuticals (PCRX)	0.4	$1.5M	59k	25.77	View chart
Novavax Com New Call Option (NVAX)	0.4	$1.5M	174k	8.67	View chart
Amylyx Pharmaceuticals (AMLX)	0.3	$1.4M	100k	13.59	View chart
Mind Medicine Mindmed Com New (MNMD)	0.3	$1.2M	106k	11.79	View chart
Anavex Life Sciences Corp Com New Call Option (AVXL)	0.3	$1.2M	140k	8.90	View chart
Skye Bioscience Com New Call Option (SKYE)	0.3	$1.2M	300k	3.93	View chart
Cormedix Inc cormedix Put Option (CRMD)	0.3	$1.2M	100k	11.63	View chart
Supernus Pharmaceuticals (SUPN)	0.3	$1.1M	22k	47.79	View chart
Editas Medicine Call Option (EDIT)	0.3	$1.0M	300k	3.47	View chart
Amicus Therapeutics Call Option (FOLD)	0.3	$1.0M	131k	7.88	View chart
Catalyst Pharmaceutical Partners (CPRX)	0.3	$985k	50k	19.70	View chart
Reviva Pharmaceutcls Hldgs I (RVPH)	0.2	$924k	2.5M	0.37	View chart
Olema Pharmaceuticals Call Option (OLMA)	0.2	$886k	91k	9.79	View chart
Trevi Therapeutics (TRVI)	0.2	$785k	86k	9.15	View chart
Puma Biotechnology Call Option (PBYI)	0.2	$722k	136k	5.31	View chart
Sellas Life Sciences Group I Com New Call Option (SLS)	0.2	$644k	400k	1.61	View chart
Xeris Pharmaceuticals (XERS)	0.2	$609k	75k	8.14	View chart
Cytomx Therapeutics (CTMX)	0.2	$591k	185k	3.19	View chart
Aytu Biopharma (AYTU)	0.1	$513k	273k	1.88	View chart
Tenaya Therapeutics (TNYA)	0.1	$511k	316k	1.62	View chart
Kodiak Sciences Call Option (KOD)	0.1	$473k	29k	16.37	View chart
Equillium (EQ)	0.1	$429k	300k	1.43	View chart
Alector (ALEC)	0.1	$403k	136k	2.96	View chart
Corvus Pharmaceuticals Put Option (CRVS)	0.1	$369k	50k	7.37	View chart
Proqr Thrapeutics N V Shs Euro (PRQR)	0.1	$336k	158k	2.13	View chart
Pyxis Oncology Common Stock (PYXS)	0.1	$333k	150k	2.22	View chart
C4 Therapeutics Com Stk Call Option (CCCC)	0.1	$312k	141k	2.22	View chart
Pelthos Therapeutics Com Shs	0.1	$294k	11k	28.00	View chart
Eliem Therapeutics (CLYM)	0.1	$274k	137k	2.01	View chart
Neuphoria Therapeutics (NEUP)	0.1	$253k	22k	11.79	View chart
Foghorn Therapeutics (FHTX)	0.1	$245k	50k	4.89	View chart
Ovid Therapeutics (OVID)	0.1	$244k	188k	1.30	View chart
Relay Therapeutics (RLAY)	0.1	$228k	44k	5.22	View chart
Ventyx Biosciences (VTYX)	0.1	$221k	71k	3.11	View chart
Moonlake Immunotherapeutics Class A Ord Call Option (MLTX)	0.0	$187k	26k	7.17	View chart
Atyr Pharma Com New Put Option (ATYR)	0.0	$148k	205k	0.72	View chart
Puretech Health Ads (PRTC)	0.0	$136k	7.3k	18.50	View chart
Avita Therapeutics Call Option (RCEL)	0.0	$128k	25k	5.11	View chart
Anaptysbio Inc Common (ANAB)	0.0	$101k	3.3k	30.62	View chart
Tvardi Therapeutics (TVRD)	0.0	$85k	2.2k	38.97	View chart
Cassava Sciences Put Option (SAVA)	0.0	$29k	9.9k	2.91	View chart
Pmv Pharmaceuticals (PMVP)	0.0	$16k	11k	1.40	View chart
Applied Therapeutics Call Option (APLT)	0.0	$12k	19k	0.60	View chart
Aurinia Pharmaceuticals Put Option (AUPH)	0.0	$7.7k	700.00	11.05	View chart
Travere Therapeutics Put Option (TVTX)	0.0	$7.2k	300.00	23.90	View chart
Jade Biosciences Com New Put Option (JBIO)	0.0	$2.8k	1.0k	2.65	View chart

Past Filings by Diadema Partners

SEC 13F filings are viewable for Diadema Partners going back to 2025

Diadema Partners 2025 Q3 filed Nov. 14, 2025

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z